In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...

Q2 2026 Earnings Call February 26, 2026 5:00 PM ESTCompany ParticipantsPaul Hughes - Joint Company SecretarySilviu Itescu ...

Improving recognition and outcomes in pelvic venous disease through embolization, with case examples. Gloria Salazar, MD, ...

Topline 6-month pivotal data expected in early Q4 2026 with potential FDA marketing application submission expected in late Q4 2026Company ...

Far Far West's frantic gunfights earn a hearty yeehaw from me.

At an event on Monday, the agency officially unveiled long-awaited draft guidance meant to help speed the development of bespoke treatments for extremely rare diseases.

Generative AI use among college students has moved well beyond an occasional shortcut into a daily habit that multiple studies associate with lower exam performance and a growing gap between what ...

In the bathroom, don’t be shocked if you see accent tiles used intermittently throughout shower surrounds, creating a ...

In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically meaningful benefit with 80+% of patients achieving ASAS40 by Week 12 Consistently, ...

Findings from a study on produce prescriptions show no significant improvement in blood sugar control, emphasizing the ...

In the 1950s, the Air Force designed cockpits for the average pilot by measuring thousands of pilots and calculating the average for 10 key physical dimensions—height, arm length, torso size, etc.

- Onvansertib added to FOLFIRI/bev first-line standard of care regimen showed dose-dependent improvement in overall response rates and durability trends as measured by progression-free survival in ...